Showing results (41-50 of 102) with videos related to
Sort By:
Pageof 11
Pathology, Research and Practice|September 8, 2018
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistanceCaterina Vicentini, Cinzia Cantù, Davide Antonello, et al.Virchows Archiv : an International Journal of Pathology|September 17, 2018
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestineMichele Simbolo, Caterina Vicentini, Andrea Mafficini, et al.Frontiers in Endocrinology|April 21, 2023
Long-term organoid culture of a small intestinal neuroendocrine tumorSabrina D'Agosto, Elena Fiorini, Francesco Pezzini, et al.The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoidsDorian R A Swarts, Aldo Scarpa, Vincenzo Corbo, et al.Annals of Surgery|September 10, 2016
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene MutationsAndrea Mafficini, Eliana Amato, Ivana Cataldo, et al.Pancreas|November 20, 2018
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysisClaudio Luchini, Nicola Veronese, Alessia Nottegar, et al.Journal of Experimental & Clinical Cancer Research : CR|January 19, 2025
The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltrationChiara Cencioni, Silvia Malatesta, Virginia Vigiano Benedetti, et al.Plos One|August 16, 2014
Reporting tumor molecular heterogeneity in histopathological diagnosisAndrea Mafficini, Eliana Amato, Matteo Fassan, et al.Scientific Reports|August 24, 2019
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic diseaseDea Filippini, Sabrina D' Agosto, Pietro Delfino, et al.Oncotarget|April 24, 2015
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinomaEmilio Bria, Sara Pilotto, Eliana Amato, et al.Pageof 11